XCL2



XCL2

M1MM1R2RR2L3LL3L4LL4I5II5L6LL6A7AA7L8LL8L9LL9G10GG10I11II11C12CC12S13SS13L14LL14T15TT15A16AA16Y17YY17I18II18V19VV19E20EE20G21GG21V22VV22G23GG23S24SS24E25EE25V26VV26S27SS27H28HH28R29RR29R30RR30T31TT31C32CC32V33VV33S34SS34L35LL35T36TT36T37TT37Q38QQ38R39RR39L40LL40P41PP41V42VV42S43SS43R44RR44I45II45K46KK46T47TT47... and 67 more residue(s)...... and 67 more residue(s)

SMILES None
InChIKey None
Sequence MRLLILALLGICSLTAYIVEGVGSEVSHRRTCVSLTTQRLPVSRIKTYTITEGSLRAVIFITKRGLKVCADPQATWVRDVVRSMDRKSNTRNNMIQTKPTGTQQSTNTAVTLTG

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

XCL2

M1MM1R2RR2L3LL3L4LL4I5II5L6LL6A7AA7L8LL8L9LL9G10GG10I11II11C12CC12S13SS13L14LL14T15TT15A16AA16Y17YY17I18II18V19VV19E20EE20G21GG21V22VV22G23GG23S24SS24E25EE25V26VV26S27SS27H28HH28R29RR29R30RR30T31TT31C32CC32V33VV33S34SS34L35LL35T36TT36T37TT37Q38QQ38R39RR39L40LL40P41PP41V42VV42S43SS43R44RR44I45II45K46KK46T47TT47... and 67 more residue(s)...... and 67 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.